The FDA has given an update on its ongoing review of a possible link between GLP-1 agonist drugs used to treat diabetes and obesity and suicide ... Ozempic for diabetes and obesity therapy Wegovy ...

Semaglutide medications like Ozempic and Wegovy have shown proven results for managing conditions like type 2 diabetes and ...

As more people resort to a new generation of drugs to achieve the perfect body, Leah Hardy examines the latest warnings over ...

Researchers say people with schizophrenia are facing an "epidemic" of obesity-related diseases, with weight gain a common ...

Although semaglutide (Ozempic, Wegovy) and other GLP-1 drugs have ... European regulators announced that a safety panel found no link between GLP-1 drugs and thyroid cancer. Nevertheless, Pearce ...

Soon after, “no food sounded appetizing,” she added ... the estimated 15 million Americans who have taken Rybelsus, Ozempic, Wegovy, or another glucagon-like peptide-1 receptor agonist ...

A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the ...

-A federal judge in Texas has upheld the U.S. Food and Drug Administration's decision to remove Novo Nordisk's blockbuster drugs Ozempic and Wegovy from the drug shortage list, rejecting a challenge ...

SHREVEPORT, La. - Many people are using cheaper versions of popular weight-loss shots like Ozempic and Wegovy. These brand-name drugs were in short supply when they first came out, so the FDA ...

In a statement, Novo Nordisk said that patient safety is a priority while maintaining the Ozempic and Wegovy are secure ... be needed to further prove a link between the ingredient and the disease.